Summit Therapeutics Inc. Depreciation
Summit Therapeutics Inc. (SMMT) reported Depreciation of $90.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-23
- Summit Therapeutics Inc. depreciation for the quarter ending 2026-06-30 was $46.00K, a 24.32% increase year-over-year.
- Summit Therapeutics Inc. depreciation for the quarter ending 2026-03-31 was $44.00K, a 76.00% increase year-over-year.
- Summit Therapeutics Inc. depreciation for the quarter ending 2025-12-31 was $42.00K, a 90.91% increase year-over-year.
- Summit Therapeutics Inc. depreciation for the quarter ending 2025-09-30 was $42.00K, a 110.00% increase year-over-year.
- Summit Therapeutics Inc. depreciation for fiscal 2025 was $146.00K, a 64.04% increase from fiscal 2024.
- Summit Therapeutics Inc. depreciation for fiscal 2024 was $89.00K, a 55.05% decline from fiscal 2023.
- Summit Therapeutics Inc. depreciation for fiscal 2023 was $198.00K, a 43.27% decline from fiscal 2022.
- Summit Therapeutics Inc. depreciation for fiscal 2022 was $349.00K, a 5.76% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 11 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $90.00K 10-Q · filed 2026-07-23 | $132.00K derived: sum of 3 quarters · filed 2026-07-23 | $174.00K derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2026-03-31 | $44.00K 10-Q · filed 2026-04-30 | $86.00K derived: sum of 2 quarters · filed 2026-04-30 | $128.00K derived: sum of 3 quarters · filed 2026-04-30 | $165.00K derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2025-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $84.00K derived: sum of 2 quarters · filed 2026-02-23 | $121.00K derived: sum of 3 quarters · filed 2026-07-23 | $146.00K 10-K · filed 2026-02-23 | ||
| 2025-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-20 | $79.00K derived: sum of 2 quarters · filed 2026-07-23 | $104.00K 10-Q · filed 2025-10-20 | $126.00K derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2025-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $62.00K 10-Q · filed 2026-07-23 | $84.00K derived: sum of 3 quarters · filed 2026-07-23 | $104.00K derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2025-03-31 | $25.00K 10-Q · filed 2026-04-30 | $47.00K derived: sum of 2 quarters · filed 2026-04-30 | $67.00K derived: sum of 3 quarters · filed 2026-04-30 | $87.00K derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $42.00K derived: sum of 2 quarters · filed 2026-02-23 | $62.00K derived: sum of 3 quarters · filed 2026-02-23 | $89.00K 10-K · filed 2026-02-23 | ||
| 2024-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-20 | $40.00K derived: sum of 2 quarters · filed 2025-10-20 | $67.00K 10-Q · filed 2025-10-20 | $97.00K derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $47.00K 10-Q · filed 2025-08-11 | $77.00K derived: sum of 3 quarters · filed 2026-02-23 | $109.00K derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-03-31 | $27.00K 10-Q · filed 2025-05-01 | $57.00K derived: sum of 2 quarters · filed 2026-02-23 | $89.00K derived: sum of 3 quarters · filed 2026-02-23 | $135.00K derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2023-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $62.00K derived: sum of 2 quarters · filed 2026-02-23 | $108.00K derived: sum of 3 quarters · filed 2026-02-23 | $198.00K 10-K · filed 2026-02-23 | ||
| 2023-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $78.00K derived: sum of 2 quarters · filed 2024-10-30 | $168.00K 10-Q · filed 2024-10-30 | $256.00K derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $136.00K 10-Q · filed 2024-08-06 | $224.00K derived: sum of 3 quarters · filed 2025-02-24 | $317.00K derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-03-31 | $90.00K 10-Q · filed 2024-05-01 | $178.00K derived: sum of 2 quarters · filed 2025-02-24 | $271.00K derived: sum of 3 quarters · filed 2025-02-24 | $370.00K derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2022-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $181.00K derived: sum of 2 quarters · filed 2025-02-24 | $280.00K derived: sum of 3 quarters · filed 2025-02-24 | $349.00K 10-K · filed 2025-02-24 | ||
| 2022-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $192.00K derived: sum of 2 quarters · filed 2023-11-07 | $261.00K 10-Q · filed 2023-11-07 | $340.00K derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $168.00K 10-Q · filed 2023-08-09 | $247.00K derived: sum of 3 quarters · filed 2023-08-09 | $328.00K derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $69.00K 10-Q · filed 2023-05-11 | $148.00K derived: sum of 2 quarters · filed 2023-05-11 | $229.00K derived: sum of 3 quarters · filed 2023-05-11 | $319.00K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $160.00K derived: sum of 2 quarters · filed 2023-03-09 | $250.00K derived: sum of 3 quarters · filed 2023-03-09 | $330.00K 10-K · filed 2023-03-09 | ||
| 2021-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $171.00K derived: sum of 2 quarters · filed 2022-11-09 | $251.00K 10-Q · filed 2022-11-09 | $286.00K derived: sum of 4 quarters · filed 2022-12-21 | ||
| 2021-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $170.00K 10-Q · filed 2022-08-11 | $205.00K derived: sum of 3 quarters · filed 2022-12-21 | $297.00K derived: sum of 4 quarters · filed 2022-12-21 | ||
| 2021-03-31 | $80.00K 10-Q · filed 2022-05-11 | $115.00K derived: sum of 2 quarters · filed 2022-12-21 | $207.00K derived: sum of 3 quarters · filed 2022-12-21 | $310.00K derived: sum of 4 quarters · filed 2022-12-21 | ||
| 2020-12-31 | $35.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-12-21 | $127.00K derived: sum of 2 quarters · filed 2022-12-21 | $230.00K derived: sum of 3 quarters · filed 2022-12-21 | $302.00K 10-K/A · filed 2022-12-21 | ||
| 2020-09-30 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $195.00K derived: sum of 2 quarters · filed 2021-11-15 | $267.00K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $103.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $175.00K 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | $72.00K 10-Q · filed 2021-05-17 | |||||
| 2019-12-31 | $321.00K 10-K · filed 2021-03-31 | |||||
| 2019-09-30 | $246.00K derived: 10-Q 9 month − 8-K 6 month · filed 2020-11-16 | $268.00K 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | $22.00K 8-K · filed 2020-09-29 | |||||
| 2019-01-31 | $409.00K 10-K · filed 2021-03-31 | $665.00K 8-K · filed 2020-09-29 | ||||
| 2018-01-31 | $198.00K 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |